Progentec
1 known investors
Progentec develops diagnostic and digital health solutions for autoimmune disease detection and treatment, including biomarker tests and remote monitoring technologies for clinicians and patients. The company focuses on improving health outcomes for the 25 million Americans living with autoimmune diseases.
BiotechDigital HealthMedical Devices
Founders & leadership
MP
Mohan PurushothamanCEO
MP
Mohan Purushothaman, Ph.D.President, Chairman, & CEO
Investors · 1
In the news
- Progentec Diagnostics - 2025 Company Profile, Funding & Competitors - Tracxntracxn.com · 2021
- i2E - 2025 Investor Profile, Team & Investment Trends - Tracxntracxn.com · 2021
- Progentec Secures $5M in Series A Funding - FinSMEsfinsmes.com · 2020
- Progentec Raises $5M in Series A Funding Led by Plains Venture Partnersprnewswire.com · 2020
- Progentec Diagnostics Completes Second Funding Round - FinSMEsfinsmes.com · 2018
- Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Managementprnewswire.com · 2018